Sensimed S.A., a Lausanne, Switzerland-based medtech company, has received a CHF3.5m equity financing from New Value AG (SIX: NEWN).Founded in 2003 as a spin-off...
eegoes, a Boston, MA-based new social network, has secured a $500,000 funding.Investors include Swiss company Mac Invest SA and Mr Ramzi Chamat.This first funding...
paper.li, a Switzerland-based online service that organizes links shared on Twitter into a newspaper-style format, has closed a new financing round of undisclosed amount. The...
NanoPowers SA, a Lausanne, Switzerland-based medical device company, closed a CHF5m (approximately $4.5m) series A financing.The round was led by seed investors in the...
Poken SA, a Lausanne, Switzerland-based provider of solutions for the events and corporate networking space, has raised $1.8m in venture financing.The round was led...
ODLO Sports Group, a Norwegian-Swiss manufacturer of functional sports underwear, has been acquired by Herkules Private Equity Fund III.Founded in Oslo in 1946, ODLO...
WISeKey, a Geneva, Switzerland-based information security and identity management software and services firm, has secured $20m pre-IPO at a $200m valuation. The round of...
Biocartis SA, a Lausanne, Switzerland-based biotech company active in the field of personalized medicine and focused on molecular diagnostics, closed its €30m (approximately $41.3m)...
Independent European Private Equity firm Argos Soditic has sold its stake in Kägi, a Swiss food processing company, to an undisclosed Swiss industrial family,...
Viroblock SA, a Plan-les-Ouates (Geneva) Switzerland-based start up dedicated to developing and commercializing a new generation of anti-viral products, has completed its Series B...
XIHA Life, a multilingual and multicultural social network based in Sunnyvale, California, Switzerland and Finland, has received $1m in seed funding.The round was led...
BioMedPartners, an European provider of private equity and mezzanine financing, closed BioMedInvest II L.P., its second healthcare venture capital fund, at CHF106m.BioMedInvest II L.P....
